Barely walk; patient experiences joint pain; receiving the third dose of SHINGRIX; This non-serious case was reported by a consumer via call center representative and described the occurrence of joint pain in a 73-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included COVID-19 VACCINE (COVID VACCINE) for prophylaxis.   The patient's past medical history included knee replacement (have 2 knee replacements). Previously administered products included Shingrix vaccine (1st and 2nd dose received on an unknown date), Shingles vaccine (old vaccine for shingles (inferred as Zostavax) predating  SHINGRIX) and Cortisone. Concurrent medical conditions included hashimoto's thyroiditis, osteoarthritis and osteoporosis.   In APR-2022, the patient received the 3rd dose of Shingrix and COVID VACCINE. In APR-2022, an unknown time after receiving Shingrix, the patient experienced extra dose administered (Verbatim: receiving the third dose of SHINGRIX). In MAY-2022, the patient experienced joint pain (Verbatim: patient experiences joint pain). On an unknown date, the patient experienced walking difficulty (Verbatim: Barely walk). The patient was treated with prednisone. The outcome of the joint pain was not resolved and the outcome of the walking difficulty was not reported and the outcome of the extra dose administered was unknown.   It was unknown if the reporter considered the joint pain and walking difficulty to be related to Shingrix.     It was unknown if the company considered the joint pain and walking difficulty to be related to Shingrix.   Additional Information: GSK receipt date: 3-AUG-2023 and 4-AUG-2023 The reporter was the patient. Nurse convinced patient that she did not have the newest Shingrix vaccine. The patient got vaccinated and the next day could barely walk. The patient have 2 knee replacements. Had cortisone shot and pack. The patient did some digging and did do the 2 doses. Now whenever she get a vaccine get terrible joint pain and have to go on prednisone. It even happened when had osteoporosis infusion. The patient was terrified to get vaccinated and also not to get them. Doctors have told not to. The patient even went to a rheumatologist and was tested poly myalgia rheumatica, tested negative. The reporter wanted any suggestions. The reporter wanted to know have GlaxoSmithKline heard of anyone else with this situation. The patient received a dose of SHINGRIX because the patient was instructed to so by an HCP (nurse). Subsequently, the patient found records that she received the full vaccination (2 doses) with SHINGRIX, when SHINGRIX first came out. Since receiving the third dose of SHINGRIX (AE - Extra Dose), the patient experiences joint pain (knees, shoulder) whenever she receives another vaccine, or when she receives an injection / infusion for treatment of osteoporosis. These events have occurred about 3-4 times since receiving the 3rd dose of SHINGRIX. The first experience with joint pain occurred 1 month after the 3rd dose of SHINGRIX when the patient received a COVID vaccine. The patient experienced joint pain with any subsequent vaccine or injection / infusion for treatment of osteoporosis.   Patient received the old vaccine for shingles (inferred as Zostavax) predating Shingrix. The patient did not recall the dates of the vaccinations for Shingrix. The patient gives consent to follow up with HCP: